214 related articles for article (PubMed ID: 8420144)
1. Mitochondrial energy crisis in Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Kondo T; Tanaka M; Ozawa T
Adv Neurol; 1993; 60():282-7. PubMed ID: 8420144
[No Abstract] [Full Text] [Related]
2. Mitochondrial complex I deficiency in Parkinson's disease.
Schapira AH
Adv Neurol; 1993; 60():288-91. PubMed ID: 8420145
[No Abstract] [Full Text] [Related]
3. Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Stocchi F; Barbato L; Carbone A; Fabbrini G; Ruggieri S; Bonamartini A; Baffigo G; Agnoli A
Adv Neurol; 1993; 60():434-7. PubMed ID: 8420168
[No Abstract] [Full Text] [Related]
4. Biochemical aspects of Parkinson's disease.
Nagatsu T
Adv Neurol; 1993; 60():165-74. PubMed ID: 8093575
[No Abstract] [Full Text] [Related]
5. Pathogenesis and animal studies of Parkinson's disease.
Oertel WH; Kupsch A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
[TBL] [Abstract][Full Text] [Related]
6. The nigrostriatal system in Parkinson's disease.
Graybiel AM; Hirsch EC; Agid Y
Adv Neurol; 1990; 53():17-29. PubMed ID: 1978514
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET.
Shinotoh H; Hirayama K; Tateno Y
Adv Neurol; 1993; 60():488-93. PubMed ID: 8420176
[No Abstract] [Full Text] [Related]
8. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
Hornykiewicz O
Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131
[No Abstract] [Full Text] [Related]
10. Early and late molecular events occurring following neuronal degeneration in the dopamine system.
Joh TH; Weiser M
Adv Neurol; 1993; 60():316-20. PubMed ID: 8093580
[TBL] [Abstract][Full Text] [Related]
11. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
Schapira AH
Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
[TBL] [Abstract][Full Text] [Related]
12. [Search for the cause of Parkinson's disease].
Langston JW
Arch Neurobiol (Madr); 1991; 54(6):264-71. PubMed ID: 1811457
[No Abstract] [Full Text] [Related]
13. Extrastriatal dopamine and Parkinson's disease.
Parent A; Cossette M
Adv Neurol; 2001; 86():45-54. PubMed ID: 11554008
[No Abstract] [Full Text] [Related]
14. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.
Chiueh CC; Miyake H; Peng MT
Adv Neurol; 1993; 60():251-8. PubMed ID: 8380519
[No Abstract] [Full Text] [Related]
15. Analysis of repetitive and nonrepetitive sequential arm movements in patients with Parkinson's disease.
Agostino R; Berardelli A; Formica A; Stocchi F; Accornero N; Manfredi M
Mov Disord; 1994 May; 9(3):311-4. PubMed ID: 8041371
[TBL] [Abstract][Full Text] [Related]
16. [Parkinson disease--a mitochondrial myopathy?].
Reichmann H; Janetzky B; Klinge M; Riederer P
Nervenarzt; 1993 Apr; 64(4):215-20. PubMed ID: 8506008
[No Abstract] [Full Text] [Related]
17. The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease.
Blandini F
Funct Neurol; 2001; 16(4 Suppl):99-106. PubMed ID: 11996537
[No Abstract] [Full Text] [Related]
18. Oxidative mechanisms in nigral cell death in Parkinson's disease.
Jenner P
Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
[TBL] [Abstract][Full Text] [Related]
19. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity.
Gash DM; Rutland K; Hudson NL; Sullivan PG; Bing G; Cass WA; Pandya JD; Liu M; Choi DY; Hunter RL; Gerhardt GA; Smith CD; Slevin JT; Prince TS
Ann Neurol; 2008 Feb; 63(2):184-92. PubMed ID: 18157908
[TBL] [Abstract][Full Text] [Related]
20. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
Hodaie M; Neimat JS; Lozano AM
Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
